Yolanda Adamczuk
Yolanda Adamczuk publishes mostly in Hematology, Internal Medicine and Rheumatology, on topics such as Blood Coagulation and Thrombosis Mechanisms, Venous Thromboembolism Diagnosis and Management and Systemic Lupus Erythematosus Research.
- World rank
- #6,950,864 of 7,710,434 ranked researchers
- Rank in Argentina
- #31,354 of 38,473
- Works
- 19
- Citations
- 314
- Citations per work
- 16.5
What does Yolanda Adamczuk research?
Yolanda Adamczuk's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1367.2%
- Medicine1367.2%
- Everything else630.8%
- Life Sciences02.0%
- 1Hematology26% of their works
- 2Internal Medicine12% of their works
- 3Rheumatology12% of their works
- 4Cardiology and Cardiovascular Medicine12% of their works
- 5Surgery4% of their works
- 6Genetics2% of their works
Research topics
- Blood Coagulation and Thrombosis Mechanisms
- Venous Thromboembolism Diagnosis and Management
- Systemic Lupus Erythematosus Research
- Platelet Disorders and Treatments
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Heparin-Induced Thrombocytopenia and Thrombosis
- Blood disorders and treatments
Which keywords describe Yolanda Adamczuk's research?
The keywords of their largest research topics: Antithrombotic Therapy, Hemostasis, Inflammation, Protease-Activated Receptors, Thrombin, Diagnosis, Antiphospholipid Syndrome and Pulmonary Embolism.
- Neutropenia
- Vaccination
- Heparin-Induced Thrombocytopenia
- Atrial Fibrillation
- Platelets
- Guidelines
- Thrombosis
- Pulmonary Embolism
- Diagnosis
- Protease-Activated Receptors
- Hemostasis
- Antithrombotic Therapy
- Inflammation
- Thrombin
- Antiphospholipid Syndrome
- Systemic Lupus Erythematosus
- Venous Thromboembolism
- Immune Thrombocytopenic Purpura
- Anticoagulant Therapy
- Acute Coronary Syndromes
- Myocardial Infarction
- Genetic Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Antithrombotic Therapy152 topics
- Hemostasis132 topics
- Inflammation132 topics
- Protease-Activated Receptors91 topic
- Thrombin91 topic
- Diagnosis82 topics
- Antiphospholipid Syndrome61 topic
- Pulmonary Embolism61 topic
- Systemic Lupus Erythematosus61 topic
- Thrombosis62 topics
- Venous Thromboembolism61 topic
- Guidelines52 topics
- Immune Thrombocytopenic Purpura41 topic
- Platelets41 topic
- Anticoagulant Therapy31 topic
- Atrial Fibrillation31 topic
- Acute Coronary Syndromes21 topic
- Heparin-Induced Thrombocytopenia21 topic
- Myocardial Infarction21 topic
- Vaccination21 topic
- Genetic Mutations11 topic
- Neutropenia11 topic
Where does Yolanda Adamczuk work?
Yolanda Adamczuk's main affiliation in the publication record is Favaloro Foundation, Argentina.
How many publications and citations does Yolanda Adamczuk have?
OpenAlex counts 19 works and 314 citations for Yolanda Adamczuk, an h-index of 10, ranking #6,950,864 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yolanda Adamczuk. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.